These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 2562847)

  • 1. Inhibition of cellular DNA synthesis by reovirus occurs through a receptor-linked signaling pathway that is mimicked by antiidiotypic, antireceptor antibody.
    Gaulton GN; Greene MI
    J Exp Med; 1989 Jan; 169(1):197-211. PubMed ID: 2562847
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isolation and biochemical characterization of the mammalian reovirus type 3 cell-surface receptor.
    Co MS; Gaulton GN; Fields BN; Greene MI
    Proc Natl Acad Sci U S A; 1985 Mar; 82(5):1494-8. PubMed ID: 3871949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-idiotypic antibody identifies the cellular receptor of reovirus type 3.
    Gaulton G; Co MS; Greene MI
    J Cell Biochem; 1985; 28(1):69-78. PubMed ID: 3875619
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reovirus type 3 and [125I]-iodocyanopindolol bind to distinct domains on the beta-adrenergic like receptor.
    Liu J; Co MS; Greene MI
    Immunol Res; 1988; 7(3):232-8. PubMed ID: 2903881
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural and Functional Features of the Reovirus σ1 Tail.
    Dietrich MH; Ogden KM; Long JM; Ebenhoch R; Thor A; Dermody TS; Stehle T
    J Virol; 2018 Jul; 92(14):. PubMed ID: 29695426
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sequences of the cell-attachment sites of reovirus type 3 and its anti-idiotypic/antireceptor antibody: modeling of their three-dimensional structures.
    Williams WV; Guy HR; Rubin DH; Robey F; Myers JN; Kieber-Emmons T; Weiner DB; Greene MI
    Proc Natl Acad Sci U S A; 1988 Sep; 85(17):6488-92. PubMed ID: 2457914
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reovirus μ1 Protein Affects Infectivity by Altering Virus-Receptor Interactions.
    Thete D; Snyder AJ; Mainou BA; Danthi P
    J Virol; 2016 Dec; 90(23):10951-10962. PubMed ID: 27681135
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural similarities between the mammalian beta-adrenergic and reovirus type 3 receptors.
    Co MS; Gaulton GN; Tominaga A; Homcy CJ; Fields BN; Greene MI
    Proc Natl Acad Sci U S A; 1985 Aug; 82(16):5315-8. PubMed ID: 2991918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reovirus type 1 and type 3 differ in their binding to isolated intestinal epithelial cells.
    Weiner DB; Girard K; Williams WV; McPhillips T; Rubin DH
    Microb Pathog; 1988 Jul; 5(1):29-40. PubMed ID: 3072462
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does the beta-adrenergic receptor function as a reovirus receptor?
    Choi AH; Lee PW
    Virology; 1988 Mar; 163(1):191-7. PubMed ID: 2831655
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Utilization of sialic acid as a coreceptor is required for reovirus-induced biliary disease.
    Barton ES; Youree BE; Ebert DH; Forrest JC; Connolly JL; Valyi-Nagy T; Washington K; Wetzel JD; Dermody TS
    J Clin Invest; 2003 Jun; 111(12):1823-33. PubMed ID: 12813018
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and use of antireceptor antibodies to study interaction of mammalian reovirus type 3 with its cell surface receptor.
    Williams WV; Weiner DB; Greene MI
    Methods Enzymol; 1989; 178():321-41. PubMed ID: 2557527
    [No Abstract]   [Full Text] [Related]  

  • 13. Infection of neuronal cell cultures with reovirus mimics in vitro patterns of neurotropism.
    Dichter MA; Weiner HL
    Ann Neurol; 1984 Nov; 16(5):603-10. PubMed ID: 6095732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential sensitivity of normal and transformed human cells to reovirus infection.
    Duncan MR; Stanish SM; Cox DC
    J Virol; 1978 Nov; 28(2):444-9. PubMed ID: 214572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Specific plasma membrane receptors for reovirus on rat pituitary cells in culture.
    Maratos-Flier E; Kahn CR; Spriggs DR; Fields BN
    J Clin Invest; 1983 Aug; 72(2):617-21. PubMed ID: 6308058
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reovirus oncolysis: the Ras/RalGEF/p38 pathway dictates host cell permissiveness to reovirus infection.
    Norman KL; Hirasawa K; Yang AD; Shields MA; Lee PW
    Proc Natl Acad Sci U S A; 2004 Jul; 101(30):11099-104. PubMed ID: 15263068
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serotonin Receptor Agonist 5-Nonyloxytryptamine Alters the Kinetics of Reovirus Cell Entry.
    Mainou BA; Ashbrook AW; Smith EC; Dorset DC; Denison MR; Dermody TS
    J Virol; 2015 Sep; 89(17):8701-12. PubMed ID: 26109733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Receptor utilization by reovirus type 3: distinct binding sites on thymoma and fibroblast cell lines result in differential compartmentalization of virions.
    Rubin DH; Weiner DB; Dworkin C; Greene MI; Maul GG; Williams WV
    Microb Pathog; 1992 May; 12(5):351-65. PubMed ID: 1501574
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Age dependent susceptibility to Reovirus type 3 encephalitis: role of viral and host factors.
    Tardieu M; Powers ML; Weiner HL
    Ann Neurol; 1983 Jun; 13(6):602-7. PubMed ID: 6309071
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms of reovirus-induced cell death and tissue injury: role of apoptosis and virus-induced perturbation of host-cell signaling and transcription factor activation.
    Clarke P; Debiasi RL; Goody R; Hoyt CC; Richardson-Burns S; Tyler KL
    Viral Immunol; 2005; 18(1):89-115. PubMed ID: 15802955
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.